{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:02:42Z","timestamp":1789070562782,"version":"build-2803163510"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Prolactin (PRL) is a hormone produced by the pituitary gland and multiple non-pituitary sites, vital in several physiological processes such as lactation, pregnancy, cell growth, and differentiation. However, PRL is nowadays known to have a strong implication in oncogenic processes, making it essential to delve into the mechanisms governing these actions. PRL and its receptor (PRLR) activate a series of effects such as survival, cellular proliferation, migration, invasion, metastasis, and resistance to treatment, being highly relevant in developing certain types of cancer. Because women produce high levels of PRL, its influence in gynecological cancers is herein reviewed. It is interesting that, other than the 23 kDa PRL, whose mechanism of action is endocrine, other variants of PRL have been observed to be produced by tumoral tissue, acting in a paracrine\/autocrine manner. Because many components, including PRL, surround the microenvironment, it is interesting to understand the hormone\u2019s modulation in cancer cells. This work aims to review the most important findings regarding the PRL\/PRLR axis in cervical, ovarian, and endometrial cancers and its molecular mechanisms to support carcinogenesis.<\/jats:p>","DOI":"10.3389\/fendo.2021.747810","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T05:54:10Z","timestamp":1634795650000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers"],"prefix":"10.3389","volume":"12","author":[{"given":"Adri\u00e1n","family":"Ram\u00edrez-de-Arellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C\u00e9sar","family":"Villegas-Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian David","family":"Hern\u00e1ndez-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Laura","family":"Pereira-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.physiol.64.081501.131049","article-title":"Prolactin: The New Biology of an Old Hormone","volume":"64","author":"Goffin","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1903","article-title":"Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy","volume":"158","author":"Ding","year":"2017","journal-title":"Endocrinology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1650343","article-title":"Association Between Prolactin Receptor Expression and Proliferation in the Endometrium of Obese Women With Polycystic Ovary Syndrome","volume":"36","author":"Paulson","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000527","article-title":"Serum Prolactin Contributes to Enhancing Prolactin Receptor and Pjak2 in Type I Endometrial Cancer Cells in Young Women Without Insulin Resistance","volume":"38","author":"Erdenebaatar","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2020.10.005","article-title":"Prolactin: A Hormone With Diverse Functions From Mammary Gland Development to Cancer Metastasis","volume":"114","author":"Karayazi At\u0131c\u0131","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.594370","article-title":"The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology","volume":"11","author":"Auriemma","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.36","article-title":"New Insights in Prolactin: Pathological Implications","volume":"11","author":"Bernard","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.celrep.2014.03.009","article-title":"Antagonism of Tumoral Prolactin Receptor Promotes Autophagy-Related Cell Death","volume":"7","author":"Wen","year":"2014","journal-title":"Cell Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0839","article-title":"Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers","volume":"16","author":"Kelly","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14526","article-title":"Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-Resistant Prostate Cancer","volume":"40","author":"Minami","year":"2020","journal-title":"Anticancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/1535-7163.MCT-12-0886","article-title":"Neutralization of Prolactin Receptor Function by Monoclonal Antibody LFA102, A Novel Potential Therapeutic for the Treatment of Breast Cancer","volume":"12","author":"Damiano","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101581","article-title":"Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases","volume":"23","author":"Hakim","year":"2020","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.09.021","article-title":"The Prolactin Receptor Transactivation Domain Is Associated With Steroid Hormone Receptor Expression and Malignant Progression of Breast Cancer","volume":"182","author":"Fiorillo","year":"2013","journal-title":"Am J Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13046-020-01564-4","article-title":"A Novel Bispecific Antibody Targeting CD3 and Prolactin Receptor (PRLR) Against PRLR-Expression Breast Cancer","volume":"39","author":"Zhou","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.726190","article-title":"Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration*","volume":"291","author":"Harrington","year":"2016","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00186","article-title":"Prolactin Promotes Breast Cancer Cell Migration Through Actin Cytoskeleton Remodeling","volume":"6","author":"da Silva","year":"2015","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12860-016-0109-5","article-title":"Prolactin-Induced PAK1 Tyrosyl Phosphorylation Promotes FAK Dephosphorylation, Breast Cancer Cell Motility, Invasion and Metastasis","volume":"17","author":"Hammer","year":"2016","journal-title":"BMC Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-0145","article-title":"Prolactin and Estrogen Up-Regulate Carboxypeptidase-D to Promote Nitric Oxide Production and Survival of MCF-7 Breast Cancer Cells","volume":"149","author":"Abdelmagid","year":"2008","journal-title":"Endocrinology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/me.2013-1202","article-title":"Prolactin\/Stat5 and Androgen R1881 Coactivate Carboxypeptidase-D Gene in Breast Cancer Cells","volume":"28","author":"Koirala","year":"2014","journal-title":"Mol Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10549-017-4223-7","article-title":"Prolactin\/androgen-Inducible Carboxypeptidase-D Increases With Nitrotyrosine and Ki67 for Breast Cancer Progression In Vivo, and Upregulates Progression Markers VEGF-C and Runx2 In Vitro","volume":"164","author":"Thomas","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"B21","article-title":"Prolactin and Androgen R1881 Induce Pro-Survival Carboxypeptidase-D and EDD E3 Ligase in Triple-Negative and HER2+ Breast Cancer","volume":"10","author":"MacDonald","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000178","article-title":"Prolactin Receptor Expression Is an Independent Favorable Prognostic Marker in Human Breast Cancer","volume":"24","author":"Hachim","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol AIMM"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.02.010","article-title":"A Favorable Role of Prolactin in Human Breast Cancer Reveals Novel Pathway-Based Gene Signatures Indicative of Tumor Differentiation and Favorable Patient Outcome","volume":"53","author":"Hachim","year":"2016","journal-title":"Hum Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/srep30934","article-title":"Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy","volume":"6","author":"L\u00f3pez-Ozuna","year":"2016","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101538","article-title":"Prolactin Hormone Exerts Anti-Tumorigenic Effects in HER-2 Overexpressing Breast Cancer Cells Through Regulation of Stemness","volume":"40","author":"Hachim","year":"2019","journal-title":"Stem Cell Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0523","article-title":"Prolactin Modulates TNBC Aggressive Phenotype Limiting Tumorigenesis","volume":"26","author":"L\u00f3pez-Ozuna","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e27318","DOI":"10.1371\/journal.pone.0027318","article-title":"The Antiangiogenic 16k Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation","volume":"6","author":"Nguyen","year":"2011","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3552","article-title":"PAI-1 Mediates the Antiangiogenic and Profibrinolytic Effects of 16K Prolactin","volume":"20","author":"Bajou","year":"2014","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.104038","article-title":"Prolactin and Cancer: Has the Orphan Finally Found a Home","volume":"16","author":"Sethi","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00469","article-title":"Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor","volume":"158","author":"Liu","year":"2017","journal-title":"Endocrinology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsbmb.2017.04.011","article-title":"Progesterone Receptors (PR) Mediate STAT Actions: PR and Prolactin Receptor Signaling Crosstalk in Breast Cancer Models","volume":"176","author":"Leehy","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-015-0234-9","article-title":"STAT3 Activation Is Required for the Antiapoptotic Effects of Prolactin in Cervical Cancer Cells","volume":"15","author":"Ramirez de Arellano","year":"2015","journal-title":"Cancer Cell Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.07.020","article-title":"Prolactin-Induced Prostate Tumorigenesis Links Sustained Stat5 Signaling With the Amplification of Basal\/Stem Cells and Emergence of Putative Luminal Progenitors","volume":"184","author":"Sackmann-Sala","year":"2014","journal-title":"Am J Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"19578","DOI":"10.1038\/s41598-019-55860-x","article-title":"Prolactin and Its Receptor as Therapeutic Targets in Glioblastoma Multiforme","volume":"9","author":"Asad","year":"2019","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/carcin\/bgt379","article-title":"Prolactin Signaling Enhances Colon Cancer Stemness by Modulating Notch Signaling in a Jak2-STAT3\/ERK Manner","volume":"35","author":"Neradugomma","year":"2014","journal-title":"Carcinogenesis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.481119","article-title":"STAT5 and Prolactin Participate in a Positive Autocrine Feedback Loop That Promotes Angiogenesis *","volume":"288","author":"Yang","year":"2013","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151507","article-title":"Prolactin Receptor Expression as a Novel Prognostic Biomarker for Triple Negative Breast Cancer Patients","volume":"46","author":"Motamedi","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-014-9814-6","article-title":"Prolactin and Prolactin Receptor Expression in Cervical Intraepithelial Neoplasia and Cancer","volume":"21","author":"Ascencio-Cedillo","year":"2015","journal-title":"Pathol Oncol Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-13-103","article-title":"High Expression of Prolactin Receptor Is Associated With Cell Survival in Cervical Cancer Cells","volume":"13","author":"Lopez-Pulido","year":"2013","journal-title":"Cancer Cell Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6222","article-title":"Pereira-Su\u00e1rez AL. A 60 kDa Prolactin Variant Secreted by Cervical Cancer Cells Modulates Apoptosis and Cytokine Production","volume":"39","author":"Ramirez De Arellano","year":"2018","journal-title":"Oncol Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.06.014","article-title":"Prolactin Increases Survival and Migration of Ovarian Cancer Cells: Importance of Prolactin Receptor Type and Therapeutic Potential of S179D and G129R Receptor Antagonists","volume":"310","author":"Tan","year":"2011","journal-title":"Cancer Lett"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.07.003","article-title":"Prolactin Signaling Drives Tumorigenesis in Human High Grade Serous Ovarian Cancer Cells and in a Spontaneous Fallopian Tube Derived Model","volume":"433","author":"Karthikeyan","year":"2018","journal-title":"Cancer Lett"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvz029","article-title":"Prolactin Enhances the Proliferation of Proliferative Endometrial Glandular Cells and Endometrial Cancer Cells","volume":"4","author":"Yamaguchi","year":"2020","journal-title":"J Endocr Soc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20810","article-title":"Prolactin Inhibits Apoptosis of Ovarian Carcinoma Cells Induced by Serum Starvation or Cisplatin Treatment","volume":"115","author":"Asai-Sato","year":"2005","journal-title":"Int J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1780265","article-title":"Prolactin Regulation of Bcl-2 Family Members: Increased Expression of bcl-xL But Not Mcl-1 or Bad in Nb2-T Cells","volume":"178","author":"Kochendoerfer","year":"2003","journal-title":"J Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(02)00008-1","article-title":"Prolactin Influences Proliferation and Apoptosis of a Human IgE Secreting Myeloma Cell Line, U266","volume":"82","author":"Gad\u00f3","year":"2002","journal-title":"Immunol Lett"},{"key":"B47","article-title":"Prolactin-Inducible EDD E3 Ubiquitin Ligase Promotes TORC1 Signalling, Anti-Apoptotic Protein Expression, and Drug Resistance in Breast Cancer Cells","volume":"9","author":"MacDonald","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16755","article-title":"Involvement of miR-106b in Tumorigenic Actions of Both Prolactin and Estradiol","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4652","article-title":"Biological Significance of Prolactin in Gynecologic Cancers","volume":"69","author":"Levina","year":"2009","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092053","article-title":"Cell Migration: Integrating Signals From Front to Back","volume":"302","author":"Ridley","year":"2003","journal-title":"Science (80-)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in Cell Biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/53.5.1247","article-title":"Prolactin-Stimulating Effect on 3H-Thymidine Incorporation in 3-Methylcholanthrene-Induced Cervical Carcinomas in Normal and Estrogenized Mice","volume":"53","author":"Forsberg","year":"1974","journal-title":"J Natl Cancer Inst"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1976.tb00131.x","article-title":"A Synergistic Effect of Oestradiol and Prolactin Influencing the Incidence of 3-Methylcholanthrene Induced Cervical Carcinomas in Mice","volume":"84","author":"Forsberg","year":"1976","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1979.tb00036.x","article-title":"Prolactin and 3-Methylcholanthrene Induced Cervical Carcinoma. Effect of Bromocriptine","author":"Forsberg","year":"1979","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(87)90023-0","article-title":"Immunocytochemical Localization of Prolactin in Carcinoma of the Cervix","volume":"26","author":"Macfee","year":"1987","journal-title":"Gynecol Oncol"},{"key":"B56","article-title":"Hyperprolactinemia as a Marker of the Progression of Cervical Cancer","volume":"36","author":"Strukov","year":"1990","journal-title":"Vopr Onkol"},{"key":"B57","article-title":"Binding and Growth-Stimulation of Cervical Cancer Cell Lines by Prolactin","volume":"91","author":"Chen","year":"1992","journal-title":"J Formos Med Assoc"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(92)90033-F","article-title":"Ectopic Production of Prolactin in Uterine Cervical Carcinoma","volume":"44","author":"Hsu","year":"1992","journal-title":"Gynecol Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1984.tb03710.x","article-title":"Absence of Prolactin Receptors in Normal and Malignant Uterine Cervix","volume":"91","author":"Dowsett","year":"1984","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6743","article-title":"Effects of 60 kDa Prolactin and Estradiol on Metabolism and Cell Survival in Cervical Cancer: Co-Expression of Their Hormonal Receptors During Cancer Progression","volume":"40","author":"Riera-Leal","year":"2018","journal-title":"Oncol Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-0935-6","article-title":"Interaction Between 17\u03b2-Estradiol, Prolactin and Human Papillomavirus Induce E6\/E7 Transcript and Modulate the Expression and Localization of Hormonal Receptors","volume":"19","author":"Ram\u00edrez-L\u00f3pez","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian Cancer Development and Metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502178102","article-title":"Serum Protein Markers for Early Detection of Ovarian Cancer","volume":"102","author":"Mor","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0619","article-title":"CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated With Tumor Growth and Metastasis","volume":"65","author":"Baumann","year":"2005","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3855","article-title":"The Metastasis-Associated Gene CD24 Is Regulated by Ral GTPase and Is a Mediator of Cell Proliferation and Survival in Human Cancer","volume":"66","author":"Smith","year":"2006","journal-title":"Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.09.067","article-title":"Susceptibility of CD24+ Ovarian Cancer Cells to Anti-Cancer Drugs and Natural Killer Cells","volume":"427","author":"Koh","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-10-0069","article-title":"New Concepts in Prolactin Biology","volume":"206","author":"Bernichtein","year":"2010","journal-title":"J Endocrinol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(02)00365-9","article-title":"IGF-2 Is a Mediator of Prolactin-Induced Morphogenesis in the Breast","volume":"3","author":"Brisken","year":"2002","journal-title":"Dev Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1200204","article-title":"Insulin-Like Growth Factor-1 Stimulates Rat Prolactin Gene Expression by a Ras, ETS and Phosphatidylinositol 3- Kinase Dependent Mechanism","volume":"16","author":"Castillo","year":"1998","journal-title":"Oncogene"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410233200","article-title":"Phosphorylation of P53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis","volume":"279","author":"Thompson","year":"2004","journal-title":"J Biol Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/471428a","article-title":"Missing the Mark","volume":"471","author":"Buchen","year":"2011","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0189641","article-title":"Diagnostic Markers for the Detection of Ovarian Cancer in BRCA1 Mutation Carriers","volume":"12","author":"Gschwantler-Kaulich","year":"2017","journal-title":"PloS One"},{"key":"B73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.canlet.2016.03.007","article-title":"Prolactin Inhibits a Major Tumor-Suppressive Function of Wild Type BRCA1","volume":"375","author":"Chen","year":"2016","journal-title":"Cancer Lett"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1454","article-title":"Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer With Enhanced Sensitivity and Specificity","volume":"77","author":"Sundaram","year":"2017","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6094","article-title":"Oncogene-Mediated Inhibition of Glycogen Synthase Kinase 3\u03b2 Impairs Degradation of Prolactin Receptor","volume":"68","author":"Plotnikov","year":"2008","journal-title":"Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biology9030044","article-title":"Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer","volume":"9","author":"Rahbar","year":"2020","journal-title":"Biology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000009685","article-title":"Human Cytomegalovirus in High Grade Serous Ovarian Cancer Possible Implications for Patients Survival","volume":"97","author":"Carlson","year":"2018","journal-title":"Med (United States)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.08.003","article-title":"Impact of Human Cytomegalovirus Infection and Its Immune Response on Survival of Patients With Ovarian Cancer","volume":"11","author":"R\u00e5destad","year":"2018","journal-title":"Transl Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0899","article-title":"NADPH Oxidase-Derived Reactive Oxygen Species Mediate Decidualization of Human Endometrial Stromal Cells in Response to Cyclic AMP Signaling","volume":"152","author":"Al-Sabbagh","year":"2011","journal-title":"Endocrinology"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/iox108","article-title":"WNK Lysine Deficient Protein Kinase 1 Regulates Human Endometrial Stromal Cell Decidualization, Proliferation, and Migration in Part Through Mitogen-Activated Protein Kinase 7","volume":"97","author":"Adams","year":"2017","journal-title":"Biol Reprod"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1177\/1933719116657894","article-title":"Decidualization Differentially Regulates microRNA Expression in Eutopic and Ectopic Endometrial Stromal Cells","volume":"24","author":"Aoyagi","year":"2017","journal-title":"Reprod Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-991042","article-title":"Decidualization of the Human Endometrium: Mechanisms, Functions, and Clinical Perspectives","volume":"25","author":"Gellersen","year":"2007","journal-title":"Semin Reprod Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gax045","article-title":"Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) Is a Novel Progesterone-Responsive Gene Required for Human Endometrial Stromal Decidualization","volume":"23","author":"Camden","year":"2017","journal-title":"Mol Hum Reprod"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e75282","DOI":"10.1371\/journal.pone.0075282","article-title":"Extracellular Signal-Regulated Kinase 1\/2 Signaling Pathway Is Required for Endometrial Decidualization in Mice and Human","volume":"8","author":"Lee","year":"2013","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.10.017","article-title":"Androgen Signaling in Decidualizing Human Endometrial Stromal Cells Enhances Resistance to Oxidative Stress","volume":"97","author":"Kajihara","year":"2012","journal-title":"Fertil Steril"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew191","article-title":"Nm23 Regulates Decidualization Through the PI3K-Akt-mTOR Signaling Pathways in Mice and Humans","volume":"31","author":"Zhang","year":"2016","journal-title":"Hum Reprod"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1210\/me.2014-1292","article-title":"FOXO1 Is Required for Binding of PR on IRF4, Novel Transcriptional Regulator of Endometrial Stromal Decidualization","volume":"29","author":"Vasquez","year":"2015","journal-title":"Mol Endocrinol"},{"key":"B88","unstructured":"Global Cancer Observatory: Cancer Today\n            FerlayJ\n            ErvikM\n            LamF\n          Int Agency Res Cancer2018"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31937","article-title":"Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"B91","unstructured":"Global Cancer Observatory: Cancer Tomorrow\n            FerlayJ\n            ErvikM\n            LamF\n          Int Agency Res Cancer2018"},{"key":"B92","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrc1781","article-title":"Predicting the Future Burden of Cancer","volume":"6","author":"Bray","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001196","article-title":"Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate","volume":"28","author":"Erdenebaatar","year":"2018","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.03.025","article-title":"Recurrence of Prolactin-Producing Endometrial Stromal Sarcoma With Sex-Cord Stromal Component Treated With Progestin and Aromatase Inhibitor","volume":"94","author":"Leiser","year":"2004","journal-title":"Gynecol Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1245","article-title":"Tumor Expression of Human Growth Hormone and Human Prolactin Predict a Worse Survival Outcome in Patients With Mammary or Endometrial Carcinoma","volume":"96","author":"Wu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-203-43581a","article-title":"Prolactin Binds to Human Endometrial Fibroblasts and Inhibits Mitogenicity of an Endometrial Carcinoma Extract","volume":"203","author":"Imai","year":"1993","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med (New York NY)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3206","article-title":"Effects of Sulpiride and Ethylene Glycol Monomethyl Ether on Endometrial Carcinogenicity in Donryu Rats","volume":"36","author":"Taketa","year":"2016","journal-title":"J Appl Toxicol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1517\/17530059.2.5.527","article-title":"Endometrial Cancer: Multiplexed Luminex Approaches for Early Detection","volume":"2","author":"Linkov","year":"2008","journal-title":"Expert Opin Med Diagn"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpsm.2015.11.003","article-title":"Spanish Consensus on the Risks and Detection of Antipsychotic Drug-Related Hyperprolactinaemia","volume":"9","author":"Montejo","year":"2016","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"B100","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ygyno.2007.05.041","article-title":"Development of Multimarker Panel for Early Detection of Endometrial Cancer. High Diagnostic Power of Prolactin","volume":"107","author":"Yurkovetsky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v18i4.17","article-title":"CA 125 Is a Better Marker to Differentiate Endometrial Cancer and Abnormal Uterine Bleeding","volume":"18","author":"Nithin","year":"2018","journal-title":"Afr Health Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-009-1228-4","article-title":"Predictive Power of Sexual Hormones and Tumor Markers in Endometrial Cancer","volume":"281","author":"Kanat-Pektas","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1246","article-title":"Opposing Actions of Intact and N-Terminal Fragments of the Human Prolactin\/Growth Hormone Family Members on Angiogenesis: An Efficient Mechanism for the Regulation of Angiogenesis","volume":"96","author":"Struman","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1042\/bj3240231","article-title":"Prolactin Stimulates the JAK2 and Focal Adhesion Kinase Pathways in Human Breast Carcinoma T47-D Cells","volume":"324","author":"Canbay","year":"1997","journal-title":"Biochem J"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1693","article-title":"Micronized Estradiol and Progesterone Therapy in Primary, Preinvasive Endometrial Cancer (1a\/G1) in Young Women With Polycystic Ovarian Syndrome","volume":"99","author":"Stanosz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1159\/000111139","article-title":"Synchronous Endometrial Carcinoma and a Macroprolactinoma: Exploring a Causal Relationship","volume":"72","author":"Sharma","year":"2007","journal-title":"Oncology"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1159\/000067769","article-title":"Sekiya S. A Case-Control Study of Endometrial Cancer After Antipsychotics Exposure in Premenopausal Women","volume":"64","author":"Yamazawa","year":"2003","journal-title":"Oncology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.747810\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T05:54:16Z","timestamp":1634795656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.747810\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":107,"alternative-id":["10.3389\/fendo.2021.747810"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.747810","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"article-number":"747810"}}